Facebook Linkedin Twitter
Inside Precision Medicine How p53 Loss Drives Cancer Risk in Ulcerative Colitis

Ulcerative colitis

Ulcerative Colitis Pains
News & Features

How p53 Loss Drives Cancer Risk in Ulcerative Colitis

0
Ulcerative Colitis Pains
News & Features

Genetic Variant Could Predict Severe Ulcerative Colitis

0
Ulcerative Colitis Pains
News & Features

Clinical Study Shows Efficacy of Monoclonal Antibody Treatment for Ulcerative Colitis

0
Biora Therapeutics
News & Features

A Pill for That: Biora’s Innovative Pills Aim to Optimize Drug Delivery

Jonathan D. Grinstein, PhD
0
Diseased colon, illustration
News & Features

AbbVie Pumps up Autoimmune Portfolio by Acquiring Landos

0
IBD, Crohn's disease, ulcerative colitis
News & Features

Thanksgiving Turkey Could Ease Ulcerative Colitis Symptoms

0
IBD, Crohn's disease, ulcerative colitis
Molecular Dx

Measurable Markers in Blood Can Be Detected Up to Eight Years Before IBD Diagnosis

0
IBD, Crohn's disease, ulcerative colitis
News & Features

Sanofi and Teva Ink Deal Worth Potentially $1.5B for Anti-TL1A IBD Candidate

0
Ulcerative Colitis Pains
Molecular Dx

AGA Releases Guidelines on Use of Fecal and Blood Tests for Monitoring Ulcerative Colitis

0
IBD, Crohn's disease, ulcerative colitis
News & Features

Prometheus’ $500M Public Offering to Fund Phase III UC, Crohn’s Studies

0
123Page 1 of 3

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine